The Ca2+ concentration impacts the cytokine production of mouse and human lymphoid cells and the polarization of human macrophages in vitro.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 25 05 2022
accepted: 06 02 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Various aspects of the in vitro culture conditions can impact the functional response of immune cells. For example, it was shown that a Ca2+ concentration of at least 1.5 mM during in vitro stimulation is needed for optimal cytokine production by conventional αβ T cells. Here we extend these findings by showing that also unconventional T cells (invariant Natural Killer T cells, mucosal-associated invariant T cells, γδ T cells), as well as B cells, show an increased cytokine response following in vitro stimulation in the presence of elevated Ca2+ concentrations. This effect appeared more pronounced with mouse than with human lymphoid cells and did not influence their survival. A similarly increased cytokine response due to elevated Ca2+ levels was observed with primary human monocytes. In contrast, primary human monocyte-derived macrophages, either unpolarized (M0) or polarized into M1 or M2 macrophages, displayed increased cell death in the presence of elevated Ca2+ concentrations. Furthermore, elevated Ca2+ concentrations promoted phenotypic M1 differentiation by increasing M1 markers on M1 and M2 macrophages and decreasing M2 markers on M2 macrophages. However, the cytokine production of macrophages, again in contrast to the lymphoid cells, was unaltered by the Ca2+ concentration. In summary, our data demonstrate that the Ca2+ concentration during in vitro cultures is an important variable to be considered for functional experiments and that elevated Ca2+ levels can boost cytokine production by both mouse and human lymphoid cells.

Identifiants

pubmed: 36827279
doi: 10.1371/journal.pone.0282037
pii: PONE-D-22-15126
pmc: PMC9956017
doi:

Substances chimiques

Calcium SY7Q814VUP
Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0282037

Informations de copyright

Copyright: © 2023 Eskiocak et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Curr Opin Immunol. 2013 Apr;25(2):161-7
pubmed: 23402834
Mediators Inflamm. 2016;2016:6152713
pubmed: 27313401
J Biol Chem. 2004 Jan 9;279(2):1415-21
pubmed: 14578353
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
Nat Immunol. 2016 Jan;17(1):34-40
pubmed: 26681460
J Clin Invest. 2014 Sep;124(9):3725-40
pubmed: 25061873
J Cell Biol. 2010 Dec 13;191(6):1113-25
pubmed: 21135141
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219
J Autoimmun. 2016 Feb;67:90-101
pubmed: 26584738
J Vis Exp. 2014 Sep 09;(91):e51554
pubmed: 25226391
Antioxid Redox Signal. 2012 Dec 15;17(12):1785-95
pubmed: 22540532
J Exp Med. 2000 Sep 4;192(5):741-54
pubmed: 10974039
Immunol Cell Biol. 2018 Mar 5;:
pubmed: 29504657
Eur J Immunol. 2015 Apr;45(4):1270-3
pubmed: 25545753
Cytotherapy. 2009;11(7):936-46
pubmed: 19903105
Nat Immunol. 2013 Nov;14(11):1146-54
pubmed: 24097110
Nat Immunol. 2017 May 18;18(6):604-611
pubmed: 28518154
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Curr Top Microbiol Immunol. 2016;393:143-174
pubmed: 26369772
Nat Rev Immunol. 2007 Sep;7(9):690-702
pubmed: 17703229
Mol Cell Biochem. 2012 Jul;366(1-2):277-85
pubmed: 22527933
iScience. 2020 Jan 24;23(1):100759
pubmed: 31887663
PLoS Pathog. 2010 Apr 22;6(4):e1000864
pubmed: 20421951
Mol Med Rep. 2019 Mar;19(3):1471-1480
pubmed: 30628681
J Vis Exp. 2011 Sep 09;(55):
pubmed: 21931292
Nat Rev Immunol. 2018 Sep;18(9):559-574
pubmed: 29967365
Nat Rev Immunol. 2019 Oct;19(10):643-657
pubmed: 31308521
Sci Rep. 2017 Nov 30;7(1):16607
pubmed: 29192280
Cell Mol Immunol. 2015 Nov;12(6):656-68
pubmed: 25864915
Anticancer Res. 2009 Mar;29(3):817-21
pubmed: 19414314
JAMA. 1967 Feb 20;199(8):519-24
pubmed: 4960081
J Exp Med. 1997 Jun 2;185(11):1977-85
pubmed: 9166427
Nat Rev Immunol. 2013 Feb;13(2):88-100
pubmed: 23348415
FEBS J. 2006 May;273(10):2077-99
pubmed: 16649987
Methods Mol Biol. 2009;485:375-91
pubmed: 19020838
Blood. 2012 Mar 8;119(10):2368-75
pubmed: 22262768
Biochem Biophys Res Commun. 2010 Jul 30;398(3):420-5
pubmed: 20599711
Nat Immunol. 2019 Sep;20(9):1110-1128
pubmed: 31406380
J Biol Chem. 2003 Jun 27;278(26):24233-41
pubmed: 12711606
Nat Immunol. 2015 Nov;16(11):1114-23
pubmed: 26482978
Cell Physiol Biochem. 2015;36(2):631-41
pubmed: 25998190
In Vitro Cell Dev Biol Anim. 2018 Sep;54(8):559-566
pubmed: 30003447

Auteurs

Yusuf Cem Eskiocak (YC)

Izmir Biomedicine and Genome Center (IBG), Balcova/Izmir, Turkey.

Zeynep Ozge Ayyildiz (ZO)

Izmir Biomedicine and Genome Center (IBG), Balcova/Izmir, Turkey.
Department of Genome Sciences and Molecular Biotechnology, Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Balcova/Izmir, Turkey.

Sinem Gunalp (S)

Izmir Biomedicine and Genome Center (IBG), Balcova/Izmir, Turkey.
Department of Genome Sciences and Molecular Biotechnology, Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Balcova/Izmir, Turkey.

Asli Korkmaz (A)

Izmir Biomedicine and Genome Center (IBG), Balcova/Izmir, Turkey.
Department of Genome Sciences and Molecular Biotechnology, Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Balcova/Izmir, Turkey.

Derya Goksu Helvaci (DG)

School of Medicine, Dokuz Eylul University, Balcova/Izmir, Turkey.

Yavuz Dogan (Y)

Department of Microbiology, Faculty of Medicine, Dokuz Eylul University, Balcova/Izmir, Turkey.

Duygu Sag (D)

Izmir Biomedicine and Genome Center (IBG), Balcova/Izmir, Turkey.
Department of Genome Sciences and Molecular Biotechnology, Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Balcova/Izmir, Turkey.
Department of Medical Biology, Faculty of Medicine, Dokuz Eylul University, Balcova/Izmir, Turkey.

Gerhard Wingender (G)

Izmir Biomedicine and Genome Center (IBG), Balcova/Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH